Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
CNY 4.02
(2.29%)
CNY 4.02
(2.29%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 69.61 Million CNY | 752.8% |
| 2022 | -10.66 Million CNY | -187.48% |
| 2021 | 12.18 Million CNY | -93.99% |
| 2020 | 202.7 Million CNY | -33.87% |
| 2019 | 306.53 Million CNY | -15.18% |
| 2018 | 361.41 Million CNY | 52.52% |
| 2017 | 236.96 Million CNY | -4.12% |
| 2016 | 247.13 Million CNY | -35.96% |
| 2015 | 385.9 Million CNY | 24.16% |
| 2014 | 310.8 Million CNY | 9.82% |
| 2013 | 283.02 Million CNY | 129.36% |
| 2012 | 123.39 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 92.9 Million CNY | -33.33% |
| 2024 Q1 | 139.34 Million CNY | 100.18% |
| 2024 Q3 | 108.09 Million CNY | 16.35% |
| 2023 Q2 | 51.58 Million CNY | -38.37% |
| 2023 Q1 | 83.7 Million CNY | 884.96% |
| 2023 FY | 69.61 Million CNY | 752.8% |
| 2023 Q4 | 69.61 Million CNY | -11.34% |
| 2023 Q3 | 78.51 Million CNY | 52.21% |
| 2022 Q3 | 170.8 Million CNY | 38.06% |
| 2022 Q1 | 98.72 Million CNY | 709.86% |
| 2022 Q2 | 123.72 Million CNY | 25.32% |
| 2022 FY | -10.66 Million CNY | -187.48% |
| 2022 Q4 | -10.66 Million CNY | -106.24% |
| 2021 Q4 | 12.18 Million CNY | -92.8% |
| 2021 FY | 12.18 Million CNY | -93.99% |
| 2021 Q2 | 199.77 Million CNY | -15.3% |
| 2021 Q3 | 169.3 Million CNY | -15.25% |
| 2021 Q1 | 235.85 Million CNY | 16.35% |
| 2020 Q4 | 202.7 Million CNY | -30.29% |
| 2020 Q2 | 310.85 Million CNY | -18.76% |
| 2020 Q1 | 382.65 Million CNY | 24.83% |
| 2020 FY | 202.7 Million CNY | -33.87% |
| 2020 Q3 | 290.8 Million CNY | -6.45% |
| 2019 Q3 | 369.66 Million CNY | 37.42% |
| 2019 Q2 | 269 Million CNY | -22.73% |
| 2019 Q4 | 306.53 Million CNY | -17.08% |
| 2019 Q1 | 348.15 Million CNY | -3.67% |
| 2019 FY | 306.53 Million CNY | -15.18% |
| 2018 Q1 | 515.35 Million CNY | 117.48% |
| 2018 FY | 361.41 Million CNY | 52.52% |
| 2018 Q4 | 361.41 Million CNY | -6.5% |
| 2018 Q3 | 386.55 Million CNY | -0.1% |
| 2018 Q2 | 386.93 Million CNY | -24.92% |
| 2017 Q3 | 428.39 Million CNY | 238.16% |
| 2017 Q4 | 236.96 Million CNY | -44.69% |
| 2017 FY | 236.96 Million CNY | -4.12% |
| 2017 Q1 | -234 Million CNY | -194.69% |
| 2017 Q2 | -310.06 Million CNY | -32.5% |
| 2016 Q1 | 201 Million CNY | 0.0% |
| 2016 Q4 | 247.13 Million CNY | 0.0% |
| 2016 FY | 247.13 Million CNY | -35.96% |
| 2015 FY | 385.9 Million CNY | 24.16% |
| 2014 FY | 310.8 Million CNY | 9.82% |
| 2013 FY | 283.02 Million CNY | 129.36% |
| 2012 FY | 123.39 Million CNY | 0.0% |